Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b
- PMID: 2849487
Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b
Abstract
The metabolic defect(s) in bone cells which manifests itself in the disease osteogenesis imperfecta (OI) type 1 is not known. Since this form of the disease displays both a variable tissue involvement and the possibility of remission it is difficult to attribute its expression to a primary mutation in the structural gene for type I collagen (as can the perinatal lethal forms of OI). In an attempt to more fully understand OI type 1 we have isolated and characterized a subpopulation of cells obtained from a sample of bone from a patient with OI type 1b. This subpopulation of cells has been shown to morphologically resemble the osteoblast phenotype, to contain the highest level of alkaline phosphatase of the cells isolated, to synthesize collagen, to respond to bone target hormones such as 1,25(OH)2D3 and parathyroid hormone, and to proliferate rapidly. Moreover, the response of these cells to the vitamin D metabolites, from the standpoint of growth regulation, is qualitatively different from normal bone cells. We intend to use these cells as a model system for studying the defect in OI type 1b.
Similar articles
-
In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.J Cell Physiol. 1993 Dec;157(3):439-44. doi: 10.1002/jcp.1041570302. J Cell Physiol. 1993. PMID: 8253854
-
Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.Micron. 2005;36(7-8):715-20. doi: 10.1016/j.micron.2005.05.014. Epub 2005 Sep 7. Micron. 2005. PMID: 16182549
-
Effects of transforming growth factor beta on cells derived from bone and callus of patients with osteogenesis imperfecta.J Orthop Res. 1993 Jul;11(4):564-72. doi: 10.1002/jor.1100110411. J Orthop Res. 1993. PMID: 8340828
-
[Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].Clin Calcium. 2009 Aug;19(8):1142-7. Clin Calcium. 2009. PMID: 19638698 Review. Japanese.
-
Osteogenesis imperfecta at the beginning of bone and joint decade.Croat Med J. 2001 Aug;42(4):393-415. Croat Med J. 2001. PMID: 11471191 Review.
Cited by
-
Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.Biochem J. 1992 Aug 15;286 ( Pt 1)(Pt 1):73-7. doi: 10.1042/bj2860073. Biochem J. 1992. PMID: 1520286 Free PMC article.
-
Prevention of heterotopic ossification: an experimental study using a plasma expander in a murine model.BMC Surg. 2016 May 4;16(1):29. doi: 10.1186/s12893-016-0144-3. BMC Surg. 2016. PMID: 27145776 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical